Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Could Amazon Be The Next Big Pharmacy Giant?

Published 05/17/2017, 02:12 AM
Updated 07/09/2023, 06:31 AM

You can buy pretty much anything you need on Amazon.com (NASDAQ:AMZN) , from books and electronics to groceries and clothes. And now, you don’t even have to make your purchases from a computer; you can conveniently buy countless items from your smartphone or tablet, an Alexa-powered smart speaker, and even one of those tiny Dash buttons.

Amazon, however, is looking to expand into new territory. According to CNBC, the e-commerce giant is trying to figure out how it can break into the multi-billion-dollar pharmacy industry.

Citing sources, CNBC reports that Amazon “has held at least one annual meeting at its Seattle headquarters to discuss whether it should enter the pharmacy business.” The company is also hiring a business lead to aid in this process, and is ready to “get more serious” about entering the pharmacy market, especially as the broader healthcare market could undergo serious change soon.

CNBC’s sources also said that Amazon has begun to recruit from the pharmacy space, and has been in “deep discussions” with industry experts. But nothing is set in stone, since there are many established players already operating in the pharmacy market, including CVS Health (NYSE:CVS) , Walgreens Boots Alliance (NASDAQ:WBA) , and Express Scripts (NASDAQ:ESRX) .

One also has to wonder how Amazon would implement its delivery methods. How would you order your prescriptions? Would prescriptions be delivered to your door through Amazon Prime? What kind of boxes would they come in? Would Amazon potentially deliver prescriptions using drones?

Amazon already sells medical supplies and equipment in the U.S., like blood pressure monitors, braces, hearing aids, and even walkers and wheelchairs. Entering the pharmacy industry does seem like a natural and lucrative next step for the company, albeit a complicated and highly regulated one.

Stocks that Aren't in the News…Yet

You are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buys" free of charge. Many of these companies are almost unheard of by the general public and just starting to get noticed by Wall Street.

They have been pinpointed by the Zacks system that nearly tripled the market from 1988 through 2015, with a stellar average gain of +26% per year. See these high-potential stocks now>>



Amazon.com, Inc. (AMZN): Free Stock Analysis Report

CVS Health Corporation (CVS): Free Stock Analysis Report

Walgreens Boots Alliance, Inc. (WBA): Free Stock Analysis Report

Express Scripts Holding Company (ESRX): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.